Home

Bin Li

CIK 1668219 · last filed 2018-09-14

Bin Li is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing shows the insider sold $14.9M of SRNE on Sep 14, 2018. Across all open-market trades the lifetime net is −$14.9M, making them a net seller over the disclosed history. 14 SEC filings were submitted jointly with Ally Bridge LB Management Ltd.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

2

Lifetime Open-Market Net

-$14.93M

Filer Profile

Reported Address
UNIT 3002-04,30TH FLOOR,GLOUCESTER TOWER
THE LANDMARK,15 QUEEN'S ROAD CENTRAL
HONG KONG, K3 000000
Related Filers
Ally Bridge LB Management Ltd — 14 joint filings, latest 2018-09-14
Fan Yu — 14 joint filings, latest 2018-09-14
ABG Management Ltd — 11 joint filings, latest 2018-09-14
ABG II-SO Ltd — 9 joint filings, latest 2018-09-14
ABG SRNE Ltd — 9 joint filings, latest 2018-09-14
Ally Bridge Group Capital Partners II, L.P. — 9 joint filings, latest 2018-09-14
Sorrento Therapeutics, Inc. — 9 joint filings, latest 2018-09-14
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Sorrento Therapeutics, Inc. (SRNE) Delisted 10%+ Owner 1,408,027 $0.00 $704 -$14.93M 1 2018-09-14
BIOCEPT INC (BIOC) Delisted 10%+ Owner 89 $0.43 $39 $0 1 2017-01-26

Recent Filings

2 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-09-14 Sorrento Therapeutics, Inc. (SRNE) Delisted Sell (S) −2,975,680 -$14.93M EDGAR
2017-01-26 BIOCEPT INC (BIOC) Delisted Disp (D) −6,724,000 -$7.40M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.